Peter W. Sonsini

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Louis Citron, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter W. Sonsini:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7,692,298 $146,153,662 $19 28 Jun 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 948,948 $1,916,875 $2.02 11 Apr 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2,563,257 $1,204,731 $0.47 22 Dec 2021 Indirect
Robinhood Markets, Inc. Director Class A Common Stock 270 $3,317 $12.28 02 May 2022 Indirect
Eargo, Inc. 10%+ Owner Common Stock 821 $2,126 $2.59 24 May 2021 Indirect
IonQ, Inc. 10%+ Owner Common Stock 70 $925 $13.21 16 Nov 2022 Indirect
Arcellx, Inc. 10%+ Owner Common Stock 12 $663 $55.27 20 Dec 2022 Indirect
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 24 $360 $15 19 Oct 2022 Indirect
Desktop Metal, Inc. 10%+ Owner Class A Common Stock 54 $40 $0.7332 08 Jun 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3,000,000 11 Apr 2022 Indirect
Bright Health Group Inc. 10%+ Owner Series B Convertible Perpetual Preferred Stock 100,000 17 Oct 2022 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.5 30 Nov 2022 Indirect
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 25 May 2022 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 28 Jun 2021 Indirect

Insider Reports Filed by Peter W. Sonsini

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACLX Arcellx, Inc. 20 Dec 2022 7 $0 4 10%+ Owner 22 Dec 2022, 17:53
AKUS Akouos, Inc. 30 Nov 2022 1 $0 4 10%+ Owner 02 Dec 2022, 16:12
IONQ IonQ, Inc. 16 Nov 2022 7 $0 4 10%+ Owner 18 Nov 2022, 16:14
AVEO AVEO PHARMACEUTICALS, INC. 19 Oct 2022 9 $0 4 10%+ Owner 21 Oct 2022, 16:53
BHG Bright Health Group Inc. 17 Oct 2022 2 $137,700,000 4 10%+ Owner 19 Oct 2022, 20:02
GNCA GENOCEA BIOSCIENCES, INC. 24 May 2022 2 -$750,662 4 10%+ Owner 26 May 2022, 18:31
HOOD Robinhood Markets, Inc. 02 May 2022 10 $0 4 Director 04 May 2022, 19:52
TRVI Trevi Therapeutics, Inc. 11 Apr 2022 3 $12,499,999 4 10%+ Owner 13 Apr 2022, 17:26
HOOD Robinhood Markets, Inc. 28 Jan 2022 10 $0 4 Director 01 Feb 2022, 18:25
BHG Bright Health Group Inc. 03 Jan 2022 2 $200,000,000 4 10%+ Owner 05 Jan 2022, 16:56
MTCR Metacrine, Inc. 10 Dec 2021 3 -$494,482 4 10%+ Owner 27 Dec 2021, 15:46
HOOD Robinhood Markets, Inc. 10 Nov 2021 4 $0 4 Director 12 Nov 2021, 15:41
HOOD Robinhood Markets, Inc. 27 Oct 2021 4 $0 4 Director, 10%+ Owner 29 Oct 2021, 17:20
TRVI Trevi Therapeutics, Inc. 18 Oct 2021 3 $0 4 10%+ Owner 19 Oct 2021, 21:15
HOOD Robinhood Markets, Inc. 02 Aug 2021 20 $77,118,720 4 Director, 10%+ Owner 03 Aug 2021, 17:52
HOOD Robinhood Markets, Inc. 29 Jul 2021 0 $0 3 Director, 10%+ Owner 29 Jul 2021, 17:54
BHG Bright Health Group Inc. 28 Jun 2021 22 $34,999,992 4 10%+ Owner 30 Jun 2021, 21:33
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 7 $19,950,000 4 10%+ Owner 30 Jun 2021, 18:08
BHG Bright Health Group Inc. 24 Jun 2021 0 $0 3 10%+ Owner 24 Jun 2021, 21:32
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 10%+ Owner 23 Jun 2021, 21:14
DM Desktop Metal, Inc. 08 Jun 2021 7 $0 4 10%+ Owner 10 Jun 2021, 16:45
EAR Eargo, Inc. 24 May 2021 4 $0 4 10%+ Owner 26 May 2021, 16:42